Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 03-Jan-24 4:30 PM View:  | Erdtmann Rainer M President and COO Director | Biomea Fusion, Inc. (BMEA) | 29-Dec-23 | Gift | 9,000 | -- | -- | < 1% 2.54M to 2.54M | |
| 03-Jan-24 4:30 PM View: | Erdtmann Rainer M President and COO Director | Biomea Fusion, Inc. (BMEA) | 29-Dec-23 | Gift | 21,000 | -- | -- | (< 1%) 2.54M to 2.52M | |
| 01-Dec-23 5:58 PM View: | Valle Franco Chief Financial Officer | Biomea Fusion, Inc. (BMEA) | 30-Nov-23 | Grant | 1,345 | $3.78 | $5,087.46 | 6% 24.2K to 25.54K | |
| 02-Jun-23 5:00 PM View: | A2a Pharmaceuticals, Inc. 10% Owner | Biomea Fusion, Inc. (BMEA) | 01-Jun-23 | Sale | 50,000 | $34.56 | $1,728,160.00 | (1%) 3.55M to 3.5M | |
| 02-Jun-23 5:00 PM View: | A2a Pharmaceuticals, Inc. 10% Owner | Biomea Fusion, Inc. (BMEA) | 31-May-23 | Private Sale | 75,000 | $33.81 | $2,535,750.00 | (2%) 3.63M to 3.55M | |
| 02-Jun-23 5:01 PM View: | Valle Franco Chief Financial Officer | Biomea Fusion, Inc. (BMEA) | 31-May-23 | Grant | 4,273 | $3.78 | $16,162.60 | 21% 19.93K to 24.2K | |
| 17-May-23 7:13 AM View: | A2a Pharmaceuticals, Inc. 10% Owner | Biomea Fusion, Inc. (BMEA) | 12-May-23 | Private Sale | 25,000 | $33.84 | $846,000.00 | (< 1%) 3.65M to 3.63M | |
| 10-May-23 5:19 PM View: | A2a Pharmaceuticals, Inc. 10% Owner | Biomea Fusion, Inc. (BMEA) | 09-May-23 | Sale | 150,000 | $34.50 | $5,175,720.00 | (4%) 3.8M to 3.65M | |
| 10-May-23 5:19 PM View: | A2a Pharmaceuticals, Inc. 10% Owner | Biomea Fusion, Inc. (BMEA) | 08-May-23 | Private Sale | 100,000 | $33.99 | $3,399,310.00 | (3%) 3.9M to 3.8M | |
| 26-Apr-23 8:36 AM View: | A2a Pharmaceuticals, Inc. 10% Owner | Biomea Fusion, Inc. (BMEA) | 20-Apr-23 | Private Sale | 200,000 | $29.12 | $5,823,760.00 | (5%) 4.1M to 3.9M | |
| 06-Apr-23 6:43 PM View: | A2a Pharmaceuticals, Inc. 10% Owner | Biomea Fusion, Inc. (BMEA) | 31-Mar-23 | Sale | 200,000 | $31.25 | $6,250,000.00 | 5% 3.9M to 4.1M | |
| 03-Apr-23 4:30 PM View: | Chen Bihua Director 10% Owner | Biomea Fusion, Inc. (BMEA) | 30-Mar-23 | Purchase | 400,000 | $30.00 | $12,000,000.00 | 13% 3.17M to 3.57M | |
| 10-Feb-23 10:00 PM View: | Erdtmann Rainer M President & COO Director | Biomea Fusion, Inc. (BMEA) | 28-Dec-22 | Gift | 12,000 | -- | -- | < 1% 2.61M to 2.62M | |
| 10-Feb-23 10:00 PM View: | Erdtmann Rainer M President & COO Director | Biomea Fusion, Inc. (BMEA) | 28-Dec-22 | Gift | 82,000 | -- | -- | (3%) 2.62M to 2.54M | |
| 02-Dec-22 10:00 PM View: | Valle Franco Chief Financial Officer | Biomea Fusion, Inc. (BMEA) | 30-Nov-22 | Grant | 2,518 | $3.78 | $9,524.33 | 14% 17.41K to 19.93K | |
| 16-Nov-22 4:30 PM View: | Hitchcock Michael J.M. Director | Biomea Fusion, Inc. (BMEA) | 14-Nov-22 | Market Purchase | 5,000 | $7.93 | $39,650.00 | 100% 0 to 5.0K | (5%) |
| 14-Nov-22 4:30 PM View: | Valle Franco Chief Financial Officer | Biomea Fusion, Inc. (BMEA) | 11-Nov-22 | Market Purchase | 4,100 | $7.63 | $31,285.90 | 31% 13.31K to 17.41K | (2%) |
| 10-Feb-23 10:00 PM View: | Erdtmann Rainer M President & COO Director | Biomea Fusion, Inc. (BMEA) | 19-Aug-22 | Gift | 16,000 | -- | -- | (< 1%) 2.63M to 2.61M | |
| 10-Feb-23 10:00 PM View: | Erdtmann Rainer M President & COO Director | Biomea Fusion, Inc. (BMEA) | 16-Aug-22 | Gift | 17,100 | -- | -- | (< 1%) 2.64M to 2.63M | |
| 19-Aug-22 6:56 AM View: | A2a Pharmaceuticals, Inc. 10% Owner | Biomea Fusion, Inc. (BMEA) | 16-Aug-22 | Private Purchase | 30,684 | $13.87 | $425,648.00 | (< 1%) 4.33M to 4.3M | |
| 25-Jul-22 7:16 PM View: | A2a Pharmaceuticals, Inc. 10% Owner | Biomea Fusion, Inc. (BMEA) | 21-Jul-22 | Private Sale | 34,658 | $11.21 | $388,516.00 | (< 1%) 4.37M to 4.33M | |
| 10-Feb-23 10:00 PM View: | Erdtmann Rainer M President & COO Director | Biomea Fusion, Inc. (BMEA) | 01-Jul-22 | Gift | 100,000 | -- | -- | (4%) 2.74M to 2.64M | |
| 28-Jun-22 7:51 AM View: | A2a Pharmaceuticals, Inc. 10% Owner | Biomea Fusion, Inc. (BMEA) | 24-Jun-22 | Private Sale | 34,658 | $11.76 | $407,578.00 | (< 1%) 4.4M to 4.37M | |
| 03-Jun-22 6:29 PM View: | Biomea Health, LLC 10% Owner | Biomea Fusion, Inc. (BMEA) | 01-Jun-22 | Disposition (other) | 4,365,340 | -- | -- | (100%) 4.37M to 0 | |
| 01-Jun-22 6:00 PM View: | Valle Franco Chief Financial Officer | Biomea Fusion, Inc. (BMEA) | 31-May-22 | Grant | 3,307 | $4.67 | $15,432.10 | 33% 10.0K to 13.31K | |
| 18-Jan-22 7:00 PM View: | Valle Franco Chief Financial Officer | Biomea Fusion, Inc. (BMEA) | 14-Jan-22 | Purchase | 10,000 | $8.68 | $86,767.00 | 100% 0 to 10.0K | |
| 21-Sep-21 10:00 PM View: | Stergiopoulos Sotirios Director | Biomea Fusion, Inc. (BMEA) | 17-Sep-21 | Market Purchase Duplicate | 34,658 | $10.96 | $379,852.00 | < 1% 4.37M to 4.4M | (4%) |
| 21-Sep-21 10:00 PM View: | A2a Pharmaceuticals, Inc. 10% Owner | Biomea Fusion, Inc. (BMEA) | 17-Sep-21 | Market Purchase | 34,658 | $10.96 | $379,852.00 | < 1% 4.37M to 4.4M | (4%) |
| 25-Aug-21 8:55 PM View: | Butler Thomas Andrew CEO Director 10% Owner | Biomea Fusion, Inc. (BMEA) | 23-Aug-21 | Market Purchase | 24,000 | $13.20 | $316,872.00 | < 1% 5.13M to 5.16M | (8%) |
| 25-Aug-21 8:56 PM View: | Erdtmann Rainer M President & COO Director 10% Owner | Biomea Fusion, Inc. (BMEA) | 23-Aug-21 | Market Purchase Duplicate | 24,000 | $13.20 | $316,872.00 | < 1% 4.9M to 4.92M | (8%) |
| 22-Apr-21 4:09 PM View: | Chen Bihua Director | Biomea Fusion, Inc. (BMEA) | 20-Apr-21 | Purchase | 900,000 | $17.00 | $15,300,000.00 | 20% 4.54M to 5.44M | |
| 22-Apr-21 4:09 PM View: | Chen Bihua Director | Biomea Fusion, Inc. (BMEA) | 20-Apr-21 | Conversion | 2,270,870 | -- | -- | 100% 2.27M to 4.54M |
